Connect with us

Featured

This New Technology Could Transform A Multi-Billion-Dollar Industry!

Joe Samuel

Published

on

On an almost daily basis, news coverage shows us that we are living constantly at risk. The U.S Justice Department defines a “mass casualty event” as any occurrence of a mass shooting, bombing, or other crime resulting in multiple fatalities. In 2019, there have already been over 80 US mass shootings[1]. On top of this, we’ve already witnessed more than 2,400 of these incidents since 2013…

…But what if there was a way to help prevent these types of events from taking place?

Taking that into consideration, all signals predict this is potentially a perfect investment opportunity for AI security solutions. Global spending on security solutions is projected to reach $103.1 billion in 2019, an increase of 9.4% over 2017, and is forecast to see growth for the next several years[2]. As an influx of investments comes into AI security solutions, we have found one company positioned to absorb!

“What we’re offering is an attack prevention system. We’re preventing someone with a weapon from entering.”

Aman Bhardwaj, COO of Liberty Defense & President Of US Operations

Liberty Defense (SCAN.V) is A Company With A Solution

Liberty Defense (SCAN.V), a leader in security and weapons detection solutions, is ready to tackle the security challenges in the urban security market with its groundbreaking HEXWAVE product.  Liberty Defense
(SCAN.V) has an exclusive license with MIT and a Technology Transfer Agreement with MIT Lincoln Laboratory for active 3D imaging technology originally developed in the MIT Lincoln Laboratory for weapon detection.

At a time where 100 Americans are killed with guns every single day and hundreds more are shot and injured, according to EveryTown Research[3], this is the time to invest in urban security. After all, what is more, valuable than a life?

What Sets Liberty Defense
(SCAN.V)’s HEXWAVE Apart From The Competition?

HEXWAVE is the first practical application of real-time, next-gen 3D imaging.  It uses low power radar energy which helps generate real-time 3D images to detect threat options such as guns, knives, explosives, and other threats through clothing and baggage. This product creates high fidelity, real-time concealed threat images which are assessed using deep learning and AI. Thus alerting security regarding the decision response hierarchy.

HEXWAVE – A Product Integrating A New Wave of Technology

·   Detects metallic and non-metallic threat objects

·   Designed for indoor/outdoor use

·   Covert and overt panel options

·   Real-time accurate detection

·   AI/deep learning enhances sensor fidelity and decision hierarchy

·   Panels can be scaled to provide a deep-layered approach

·   Can be used stand-alone or combined with other security measures

HEXWAVE provides enhanced security options without disrupting the flow of daily life by scanning quickly and unobtrusively. Ideal for use in high traffic areas and a huge leap from the traditional metal detector. 

The demand is present andLiberty Defense (SCAN.V) has already inked two Memorandums of Understanding for beta testing of HEXWAVE, which is expected to commence this year! With Canada’s Rogers Arena, Vancouver’s large-scale venues and Sleiman Enterprises, one of Florida’s largest real estate companies developing and managing malls, hotels, and shopping centers, Liberty Defense (SCAN.V) has created a strong pipeline of premier customers.

Liberty Defense (SCAN.V)’s All-Star Management

Advancement from the operational to strategic level is a crucial undertaking that all companies must undergo in pursuit of success. The executive leadership team at Liberty Defense (SCAN.V) has the necessary insight to achieve profitable growth and maintain operational systems.

Liberty Defense (SCAN.V) s President Of US Operations and Chief Operating Officer, Aman Bhardwaj, comes with over 20 years of strategic experience and involvement with large multinational startups, such as Panasonic and Flextronics. Bhardwaj’s vast involvement and leading global large-scale companies serve as an invaluable asset to the company.

Bill Riker, the company’s chief executive officer, joined Liberty Defense (SCAN.V) back in August 2018. Since then, Riker has played a key role in establishing the company as an industry leader in the urban security market. Prior to joining Liberty Defense (SCAN.V)’s leadership team, Riker racked up extensive experience in several companies focused on threat detection solutions, and identification of chemical, radiological, nuclear and explosive threats for the global security market and held an executive position in the US Department of Defense.

Liberty Defense (SCAN.V) chief technology officer, Bart Smudde, brings over 30 years of experience to the table in designing, testing and manufacturing electronics products in several markets including military and medical.  Smudde has managed engineering teams for companies including Graco, Landis+Gyr, SignalONE Safety, and Panasonic.

And in early May, 2019, Liberty Defense (SCAN.V) brought on Ron Solanki as VP Operations of its US Subsidiary. Mr. Solanki has held leadership positions with major multi-national global electronics corporations such as Motorola, Panasonic, Flextronics and Hisense. With over 30 years of experience delivering results in high-tech company operations, he’s help build businesses around strategic business management and development, R&D, manufacturing, supply chain, and legal affairs. He has also served on international boards of directors and business & technology advisory boards.

Liberty Defense (SCAN.V)’s Opportunities Ahead For Detection

Specifically, the Weapons Detection Systems Market is forecast to grow from USD $5.3 billion in 2020 to $7.5 billion by 2025, at a compound annual growth rate of 8.2%[4].  With the political spotlight focused now more than ever on gun control and public safety, emerging companies in this sector are poised for increased opportunities and growth.

Patriot Tech (PAT.V) (PTOTF), for instance, has generated some buzz lately.  This emerging company has been prequalified for up to CA$1 million from the federal government’s Build in Canada Innovation Program for testing by the Department of National Defense to test its covert weapon detection system[5].  The system uses cognitive microwave radar to detect hidden guns, knives, and other threats.  With the potential for a government to back such technology, if all goes well, this may catalyze opportunity for advancements throughout the sector and Liberty Defense (SCAN.V).

With the potential technology to revolutionize the standards of security, Liberty Defense (SCAN.V) is seeking to become a market leader and take a seat at the table with companies like major government contractor L3 Technologies (LLL) who provides detection and security systems for U.S. Department of Defense, Homeland Security and foreign governments or leading tech innovator Harris Corp. (HRS) which supports government and commercial customers in over 100 countries.  Liberty Defense (SCAN.V) may provide investors with the opportunity to take part in this rapidly growing market early on.

“Currently, there is a significant gap that must be addressed in urban security threat defense. HEXWAVE provides a wider perimeter for early detection beyond just the point solution typically positioned at an entrance of a facility. This essential layer will enable security measures to be proactively deployed to detect a threat before it transitions to an attack condition. Liberty Defense (SCAN.V) can fill this gap,” said Bill Riker, CEO of Liberty Defense (SCAN.V).

A Strategy That Builds Partnerships

In Mid-April, Liberty Defense (SCAN.V) expanded on its strategic initiatives. This includes testing and implementing the company’s HEXWAVE product at major epicenters of security risks. Furthermore, the proposed testing of its product with its Vancouver Arena Limited Partnership will occur at a site to be determined within or near Rogers Arena in Vancouver, BC.

In the coming months, we expect to be able to announce a number of key partnerships through our MOU program that will not only help validate the opportunities for this type of technology but also show the depth and reach of the Company and its Advisors.”

Bill Riker, CEO of Liberty Defense (SCAN.V)

To give some perspective on the scope of this opportunity, Rogers Arena is one of the premier sports and entertainment facilities in North America. It has hosted over 25 million fans with a proud legacy of success. Events include NHL hockey games and most of the largest concerts and shows in the city. It was also the site where the Canadian women’s and men’s hockey teams won gold medals during the Vancouver 2010 Olympic Winter Games.

KEY DEVELOPMENT: Liberty Defense (SCAN.V) Signs MOU with the Utah Attorney General for Testing of HEXWAVE

Liberty Defense Holdings Ltd. (TSXV: SCAN) announced that it has signed a memorandum of understanding (MOU) with the Office of the Utah Attorney General to beta test HEXWAVE in the state.

The Utah Attorney General, Sean Reyes , is an elected constitutional officer in the executive branch of the state government of Utah . The attorney general is the chief legal officer and legal adviser in the state.

Can You Detect A Winner?

We live in a world where threats to our safety, both large and small, have impacted the way we as a society live.  Increased security measures are being taken in several aspects of daily life such as entering a school or even a baseball game, often causing large delays.  Worse off, not all current security measures are stopping these threats before they happen.  

Liberty Defense (SCAN.V) is working on a solution to combat these issues head on through the implementation of its HEXWAVE product. As we move towards the future, it could be potentially lucrative for investors to pay attention to this sector and Liberty Defense (SCAN.V) early on, and you heard it here first!


Endnotes:

[1]https://www.massshootingtracker.org/

[2] https://www.globaldots.com/worldwide-spending-on-security-solutions-expected-to-continue-growing/

[3]https://everytownresearch.org/gun-violence-america/

[4] https://homelandsecurityresearch.com/reports/explosives-detection-systems-market-technologies-industry

[5] https://finance.yahoo.com/news/patriot-one-pre-qualifies-1-130000035.html


Disclaimer:

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 04/15/2018 – 5/15/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter now extended through June 21, 2019. We were paid $350,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. FULL DISCLAIMER HERE

Continue Reading
Click to comment

Biotechnology

Acadia (ACAD) Stock Price is up 60% This Month; Bullish Signal For Biotechs?

Joe Samuel

Published

on

One sector that has always been a favorite of investors of all varieties is the pharmaceutical sector and all investors like a turnaround story. Over the years, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had been one of the better-known strugglers in the industry. That was reflected in the stock price as well. But recent developments have breathed new life in the stock, which could be an indicator for the biotech industry at large.

Biotech Stocks To Watch: PharmaCyte Biotech (PMCB)

There has been no lack of attention on biotech penny stocks this year.  At the beginning of August, one small biotech stock broke to highs of over $10 from a starting price below $2 a share after releasing news. PharmaCyte Biotech (PMCB) focuses on ways to effectively deliver treatments to patients with diseases ranging from cancer to diabetes. 

The company’s proprietary cellulose-based live-cell encapsulation technology known as “Cell-in-a-Box®is the platform that the company uses to develop its therapy delivery methods.  For most of the quarter, shares of PMCB stock have traded between $0.033 and $0.04 with volume recently surging.

On September 12, PharmaCyte saw more than 4 million shares trade; well above its daily average. Most of the attention surrounding the company has been on two things. First, its progress with Cell-In-A-Box and the application for Pancreatic cancer has continued to progress. The company brought on Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC) now that he is at Weill Cornell Medical Center.

Second, the company has been ramping up for a much-anticipated shareholder update call on September 20. The call will cover PharmaCyte’s preparations for submission of its Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) to treat locally advanced, inoperable pancreatic cancer and developments related to PharmaCyte’s product pipeline on which PharmaCyte has been working and that have not yet been reported in a press release.

Acadia (ACAD) Stock Price: Important Developments

People who had held on to the stock through the barren years got a nice boost recently. This came after Acadia’s well-known medicine Nuplazid recorded better than expected sales. In addition to that, there were encouraging results from a dementia-driven psychosis study. Hence, it is important to figure out whether it is perhaps time to buy the stock.

While the signs are no doubt encouraging, it is important to note that data reveals that around 60,000 people in the United States are diagnosed with Parkinson’s every year. Out of those, a large proportion (50% to 80%) suffers from dementia. Hence it can be argued that the market is simply not too big for Acadia’s Nuplazid.

Moreover, different types of dementia are brought on by Alzheimer’s disease, which is why all of it might not actually fall into Acadia’s lap. That being said, it is also well known that antipsychotic drugs have only been approved for the treatment of Parkinson’s and hence the Alzheimer’s market is already out of the question.

Market Potential

Projections suggest that the sale of Nuplazid could grow to more than $1 billion in 2023 from $224 million in 2018. While that is encouraging, it is also important to note that the growth has been priced into the Acadia stock price.

However, if Acadia’s plans for growth somehow run into any trouble, then there is every chance of the stock price plummeting once again. The company is recovering and there is some time before the patient population for Nuplazid can be expanded sufficiently. In the meantime, investors need to be a bit more patient.

Shares of ACAD are up over 60% over the past week and made a new multi-year high of $43.98.

biotech stock price
Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 9/12/2019. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Continue Reading

Featured

Advanced Micro Devices (AMD) Stock Price Consolidates After the Recent Rally: What Next?

Jon Phillip

Published

on

technology stocks

It sometimes so happens that the price action and activity around a stock reaches a decisive stage, from which it can go only one way or another. In other words, it is the moment when the future of a stock is a straight shootout between the bulls and the bears.

The Advanced Micro Devices, Inc. (NASDAQ:AMD) stock has now reached such a stage according to keen observers and hence the stock is now trading within a very narrow range as the squeeze continues. In such a situation, it is only natural for investors to wonder which way this whole thing is going to go in the short term.

Key Analysis

First and foremost, it is important to point out that since Lisa Su took over as the Chief Executive Officer in 2014, AMD has managed to stage a remarkable turnaround. Although the process has been slow, it proved to be highly lucrative for those investors who were patient. The stock has risen steadily over the past three years and rallied from $2 to around $30.

However, at the time, the investors had backed the company’s turnaround but now the story has changed and the turnaround has concluded. The bulls seem to think that the run is going to continue while bears believe that with the conclusion of the turnaround, the stock is all set to fall.

After all, if there is no further upside, then there is no point in holding the stock. This has caused uncertainty in the stock and its price action. Analysts believe that while the turnaround story had resulted in enormous gains for many investors, the stock is now expected to mirror the performance of the broader market. This factor lays credence to the bears’ position and moreover, the small matter of a looming Presidential election needs to be considered as well. Markets are generally flat in the lead-up and hence, analysts believe that although AMD might continue to be range-bound, it is unlikely that it is going to go on a rally.

Continue Reading

Featured

Stock Price Newsletter – September 18, 2019

Joe Samuel

Published

on

biotech stock to watch 2019

4 Penny Stocks Catching Attention This Week

Several economic and sector events have sparked interest in a number of small-cap and micro-cap stocks this week.

See For Yourself


Airline Stocks In Focus; Spur Interest In Detection Tech Companies?

The latest mix of attacks and focus on airlines could have a different impact on sectors like weapons detection & defense. What could this mean for stocks to watch this week?

Click Here To Read More


Top Biotech Stocks To Watch This Week

The values of biotech equities, however, do generally start to pick up as the year winds down. The underlying reason is that the latter part of the year is chock-full of key data readouts, regulatory decisions, and thousands of scientific conferences across the globe. 

Click Here To Read More

Click Here For Full Disclaimer

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com